Dongxu Sun is the founder of TrueBinding. TrueBinding has raised $100M in total funding. Latest round: Series A. Based in Foster City, CA.
Dongxu Sun, PhD, is the CEO of TrueBinding Inc., a biopharmaceutical company founded in 2016 that develops monoclonal antibody drugs for Alzheimer's disease and dementia. He leads the company's efforts on its lead candidate TB006, which has shown improved cognition and function in Phase 2a clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library